Figure 5.
Figure 5. Phenotype of GAD TMr-treated anergic T cells. (A-D) Ann-V- high- and low-avidity T cells were sorted after TMr treatment and analyzed for CD25 and CTLA-4 expression by flow cytometry. Profiles of control and GAD TMr-treated T cells are shown in gray and black, respectively. (E) Western blot of FoxP3 expression in high- and low-avidity T cells. The membrane was probed with an anti-FoxP3 antiserum (top) and subsequently with an anti-TFIIB Ab (bottom) to verify equal loading of lanes. The band obtained from FoxP3-transfected 293T cells is shown as control in the last lane. Bar graph shows densitometric analysis of FoxP3 bands normalized to TFIIB bands detected in each lane.

Phenotype of GAD TMr-treated anergic T cells. (A-D) Ann-V- high- and low-avidity T cells were sorted after TMr treatment and analyzed for CD25 and CTLA-4 expression by flow cytometry. Profiles of control and GAD TMr-treated T cells are shown in gray and black, respectively. (E) Western blot of FoxP3 expression in high- and low-avidity T cells. The membrane was probed with an anti-FoxP3 antiserum (top) and subsequently with an anti-TFIIB Ab (bottom) to verify equal loading of lanes. The band obtained from FoxP3-transfected 293T cells is shown as control in the last lane. Bar graph shows densitometric analysis of FoxP3 bands normalized to TFIIB bands detected in each lane.

Close Modal

or Create an Account

Close Modal
Close Modal